Nonpharmacologic supportive care for 
infants with NAS 


Parents of infants with NAS should be counseled on 
evidence-based, supportive treatments to implement after hospital discharge. Swaddling techniques may help minimize fussiness and agitation, and may be particularly useful during feedings. 


Poor motor control also can contribute to poor feeding. For example, the infant may turn his or her head from side to side vigorously when the nipple or pacifier is brought close to the mouth. Helping to steady the head will be helpful in these instances.12



Continue Reading

Nonpharmacologic supportive care for infants with neonatal abstinence syndrome
  • Decrease environmental stimuli
  • Use tight swaddling; position on side or back in “C” curve
  • Apply pressure over infant’s head and body for calming effects
  • Cluster infant-care activities with gentle handling
  • Encourage non-nutritive sucking
  • Use small, frequent feedings, with hypercaloric formula if needed
  • The baby should be breastfed if possible.
  • Bright lights, excessive noise, and other sensory stimulation should be kept to a minimum. It is essential that the infant be monitored closely for weight gain and for the development of other diseases. 


    Conclusion


    As the use of illicit drugs by pregnant women increases, so does the number of infants who develop signs and symptoms of NAS, the prevalence of which is most pronounced in infants exposed to opioids.

    Nonpharmacologic management with supportive measures to ameliorate the infant’s CNS, GI, and autonomic disturbances are the standard of care, regardless of the need for pharmacologic intervention.

    Given the increased medical and developmental risks infants with NAS face, adequate nutrition to meet the increased caloric needs is essential for weight gain and growth. Small, frequent feedings with hypercaloric infant formula given in a low-stimulus environment, alone or as a supplement to breastfeeding, are recommended. 


    HOW TO TAKE THE POST-TEST: Click here after reading the article to take the post-test on myCME.com.


    References

    1. Jones HE, Kaltenbach K. Neonatal abstinence syndrome. JAMA. 2012;308:762-763.
    2. Hudak ML, Tan RC, The Committee on Drugs, The Committee on Fetus and Newborn Neonatal Drug Withdrawal. Pediatrics . 2012;129:e540-e560. Available at pediatrics.aappublications.org/content/129/2/e540.full.pdf+html.
    3. Allen RE, Myers AL. Nutrition in toddlers. Am Fam Physician . 2006;74: 1527-1532. Available at www.aafp.org/afp/2006/1101/p1527.html.
    4. Wendell AD. Overview and epidemiology of substance abuse in pregnancy. Clin Obstet Gynecol . 2013;56:91-96.

    5. Patrick SW, Schumacher RE, Benneyworth BD, et al. Neonatal abstinence syndrome and associated health care expenditures: United States, 2000-2009. JAMA . 2012;307:1934-1940. Available at jama.jamanetwork.com/article.aspx?articleid=1151530&resultClick=3.
    6. Behnke M, Smith VC, Committee on Substance Abuse, Committee on Fetus and Newborn. Prenatal substance abuse: short- and long-term effects on the exposed fetus. Pediatrics . 2013;131:e1009-e1024. Available at pediatrics.aappublications.org/content/131/3/e1009.full.pdf+html.
    7. Queensland Maternity and Neonatal Clinical Guidelines Program. Neonatal abstinence syndrome. 2010; Queensland, Australia. Available at www.health.qld.gov.au/qcg/documents/g_nas5-0.pdf.
    8. Logan BA, Brown MS, Hayes MJ. Neonatal abstinence syndrome: treatment and pediatric outcomes. Clin Obstet Gynecol . 2013;56:186-192.

    9. March of Dimes. Available at http://www.marchofdimes.com/baby/neonatal-abstinence-syndrome-%28nas%29.aspx.
    10. University of Iowa. Neonatal abstinence syndrome. Available at 
www.uiowa.edu/~medtest3/nas/NAS.pdf
    11. Finnegan LP, Connaughton JF Jr, Kron RE, Emich JP. Neonatal abstinence syndrome: assessment and management. Addict Dis . 1975;2:141-158.

    12. Velez ML, Jansson LM, Schroeder J, Williams E. Prenatal methadone exposure and neonatal neurobehavioral functioning. Pediatr Res . 2009;66:704-709.

    13. Sublett J. Neonatal abstinence syndrome: therapeutic interventions. MCN Am J Matern Child Nurs . 2013;38:102-107
    14. Pritham UA. Breastfeeding promotion for management of neonatal abstinence syndrome. J Obstet Gynecol Neonatal Nurs . 2013;42:517-526.
    15. McQueen KA, Murphy-Oikonen J, Gerlach K, Montelpare W. The impact of infant feeding method on neonatal abstinence scores of methadone-exposed infants. Adv Neonatal Care. 2011;11:282-290.
    16. American Academy of Pediatrics Committee on Drugs. Neonatal drug withdrawal. Pediatrics . 1998;101(6):1079-1088. Available at pediatrics.aappublications.org/content/121/1/106.full.pdf+html. 

    17. Jansson LM, Choo R, Velez ML, et al. Methadone maintenance and breastfeeding in the neonatal period. Pediatrics . 2008;121:106-114. Available at pediatrics.aappublications.org/content/101/6/1079.full.pdf+html. 

    18. American Academy of Pediatrics Committee on Drugs. The 
transfer of drugs and other chemicals into human milk. Pediatrics . 2001;108:776-789. Available at pediatrics.aappublications.org/content/108/3/776.full.pdf+html.

    19. Minnes S, Lang A, Singer L. Prenatal tobacco, marijuana, stimulant, and opiate exposure: outcomes and practice implications. Addict Sci Clin Pract . 2011;61:57-70. Available at www.ncbi.nlm.nih.gov/pmc/articles/PMC3188826/

    All electronic documents accessed June 4, 2014.